[Development of bacterial resistance against trimethoprim-sulfamethoxazole (Eusaprim)].
D001419:Bacteria / Q000187:drug effects*; D002509:Cephaloridine / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D003470:Culture Media; D013293:Enterococcus faecalis / Q000187:drug effects; D004917:Erythromycin / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects; D005111:Extrachromosomal Inheritance; D005839:Gentamicins / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology; D011511:Proteus / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects; D013420:Sulfamethoxazole / Q000494:pharmacology*; D013752:Tetracycline / Q000494:pharmacology; D014295:Trimethoprim / Q000494:pharmacology*
D003470:Culture Media; D005839:Gentamicins; D010406:Penicillins; D004917:Erythromycin; D002701:Chloramphenicol; D014295:Trimethoprim; D013752:Tetracycline; D013420:Sulfamethoxazole; D002509:Cephaloridine
Zur Resistenzentwicklung von Bakterien gegen Trimethoprim-Sulfamethoxazol (Eusaprim.